WHWouter Frederik Johan Hogendorf

Wouter Frederik Johan Hogendorf

*This is an algorithmically generated author record based on publicly available information.

Wouter Frederik Johan Hogendorf has a total of 88 co-authors. Here are the top co-authors by number of shared publications:

  • Tine Glendorf

    Novo Nordisk A/S, Research and Early Development, Måløv, Denmark

    2 shared publications
  • Aaron Novikoff

    Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Munich, Neuherberg, Germany

    1 shared publication
  • Abigail J. Tomlinson

    Departments of Internal Medicine, University of Michigan and Molecular and Integrative Physiology, Ann Arbor, USA

    1 shared publication
  • Ahmed Khalil

    Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Munich, Neuherberg, Germany

    1 shared publication
  • Aimée Bastidas-Ponce

    German Center for Diabetes Research (DZD), Neuherberg, Germany

    1 shared publication
  • Andreas Vegge

    Novo Nordisk A/S, Research and Early Development, Måløv, Denmark; Novo Nordisk A/S, Development, Søborg, Denmark

    1 shared publication

Latest Publications

  • Open Access

    Machine Learning-Guided Discovery of Robust Conditions for Photochemical Nickel-Catalyzed Cysteine Arylation

    by Nikolaos Kaplaneris, Elia Savino, Zhen He, Naya Stini, Michael Vanzella, Méritxell Fillols, Petros Siasiaridis, Oliver Bayley, Kim Halskov, Wouter Hogendorf, et al.

    Late-stage functionalization (LSF) of peptides offers direct access to structurally diverse analogues, but developing general, chemoselective protocols remains challenging due to the complexity of peptide substrates and the vast number of reaction variables. Traditional optimization methods are slow and resource-intensive, limiting the exploration of new chemistries. Here, we present a machine learning (ML)-guided workflow that rapidly identifies robust and scalable conditions for the nickel-catalyzed photochemical arylation of cysteine residues. Using arylthianthrenium salts as versatile electrophiles and graphitic carbon nitride as a sustainable photocatalyst, we implemented a two-stage active learning strategy: first, an embedding-based model to efficiently narrow the categorical space, followed by Bayesian optimization of continuous parameters. Importantly, this ML-guided workflow pairs seamlessly with conventional laboratory practices, eliminating the need for specialized high-throughput experimentation (HTE) equipment such as microtiter plates. This approach enabled the discovery of high-yielding, chemist-friendly conditions with minimal experimental cost. The resulting protocol shows high site- and chemoselectivity across diverse peptides, saccharides and the (hetero)arylthianthrenium coupling partners, and can be scaled to gram quantities while allowing photocatalyst recycling. More broadly, this work demonstrates how data-driven optimization can accelerate the development of general LSF methodologies, providing a transferable strategy for modern reaction discovery.


  • Open Access

    The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats

    by Rune Ehrenreich Kuhre, Borja Ballarín-González, Christian Lehn Brand, Tine Glendorf, Kim Grimstrup Madsen, Karina Rahr Hjøllund, Wouter Frederik Johan Hogendorf, David Højland Ipsen, Sofia Lundh, Thomas Kruse, et al.


  • Glp1r-Lepr coexpressing neurons modulate the suppression of food intake and body weight by a GLP-1/leptin dual agonist

    by Joseph Polex-Wolf, Kristine Deibler, Wouter Frederik Johan Hogendorf, Sarah Bau, Tine Glendorf, Carsten Enggaard Stidsen, Christian Wenzel Tornøe, Dong Tiantang, Sofia Lundh, Charles Pyke, et al.

    Glucagon-like peptide-1 (GLP-1) and leptin signal recent feeding and long-term energy stores, respectively, and play complementary roles in the modulation of energy balance. Previous work using single-cell techniques in mice revealed the existence of a population of leptin receptor ( Lepr )–containing dorsomedial hypothalamus (DMH) neurons marked by the expression of GLP-1 receptor ( Glp1r ; LepR Glp1r neurons) that play important roles in the control of feeding and body weight by leptin. Here, we demonstrate the existence of a population of LepR Glp1r neurons in the DMHs of nonhuman primates (NHPs), suggesting the potential translational relevance of these neurons. Consequently, we developed a GLP-1R/LepR dual agonist and demonstrated the physiological activity of both components in vivo using leptin-deficient and Lepr- deficient murine models. We further found roles for LepR Glp1r neurons in mediating the dual agonist’s efficacy on food intake and body weight loss. Ablating Lepr in Glp1r -expressing neurons (Lepr Glp1r KO mice) abrogated the suppression of food intake by the dual agonist. Furthermore, reactivation of Glp1r expression in Lepr neurons on an otherwise Glp1r -null background (Glp1r Lepr Re mice) was sufficient to permit the suppression of food intake and body weight by the dual agonist. Hence, LepR Glp1r neurons represent targets for a GLP-1R/LepR dual agonist that potently reduces food intake and body weight.


  • Open Access

    Photochemically-enabled, post-translational production of C-terminal amides

    by David Hymel, Felix Wojcik, Kim S. Halskov, Wouter F. J. Hogendorf, Sydnee C. Wong, Ben M. Williams, Asmus R. Mortensen, Nick Cox, Ayesha Misquith, Nanna B. Holländer, et al.

    C-terminal α-amidated peptides are attractive therapeutic targets, but preparative methods to access amidated pharmaceuticals are limited both on lab and manufacturing-scale. Here we report a straightforward and scalable approach to the C-terminal α-amidation of peptides and proteins from cysteine-extended polypeptide precursors. This amidation protocol consists of three highly efficient steps: 1) selective cysteine thiol substitution with a photolabel, 2) photoinduced decarboxylative elimination and 3) enamide cleavage by simple acidolysis or inverse electron demand Diels-Alder reaction. We provide a blueprint for applying this protocol to the semi-recombinant production of therapeutically relevant targets where gram scale C-terminal α-amidation is achieved in a photoflow reactor on a recombinantly prepared peptide YY analogue and a GLP-1/amylin co-agonist precursor peptide. Robust performance of this reaction cascade in flow highlights the potential of this chemistry to enable amidated drug leads to enter development that would not be viable on commercial scale using existing technology.


  • Open Access

    Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice

    by Arkadiusz Liskiewicz, Ahmed Khalil, Daniela Liskiewicz, Aaron Novikoff, Gerald Grandl, Gandhari Maity-Kumar, Robert M. Gutgesell, Mostafa Bakhti, Aimée Bastidas-Ponce, Oliver Czarnecki, et al.

    The development of single-molecule co-agonists for the glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide (GIP) receptor (GIPR) is considered a breakthrough in the treatment of obesity and type 2 diabetes. But although GIPR–GLP-1R co-agonism decreases body weight with superior efficacy relative to GLP-1R agonism alone in preclinical1–3 and clinical studies4,5, the role of GIP in regulating energy metabolism remains enigmatic. Increasing evidence suggests that long-acting GIPR agonists act in the brain to decrease body weight through the inhibition of food intake3,6–8; however, the mechanisms and neuronal populations through which GIP affects metabolism remain to be identified. Here, we report that long-acting GIPR agonists and GIPR–GLP-1R co-agonists decrease body weight and food intake via inhibitory GABAergic neurons. We show that acyl-GIP decreases body weight and food intake in male diet-induced obese wild-type mice, but not in mice with deletion of Gipr in Vgat(also known as Slc32a1)-expressing GABAergic neurons (Vgat-Gipr knockout). Whereas the GIPR–GLP-1R co-agonist MAR709 leads, in male diet-induced obese wild-type mice, to greater weight loss and further inhibition of food intake relative to a pharmacokinetically matched acyl-GLP-1 control, this superiority over GLP-1 vanishes in Vgat-Gipr knockout mice. Our data demonstrate that long-acting GIPR agonists crucially depend on GIPR signaling in inhibitory GABAergic neurons to decrease body weight and food intake.


  • Fluorous Linker Facilitated Synthesis of Teichoic Acid Fragments

    by Wouter F. J. Hogendorf, Lucien N. Lameijer, Thomas J. M. Beenakker, Herman S. Overkleeft, Dmitri V. Filippov, Jeroen D. C. Codée, Gijsbert A. Van der Marel

    The use of perfluorooctylpropylsulfonylethanol as a new phosphate protecting group and fluorous linker is evaluated in the stepwise solution phase synthesis of a number of biologically relevant (carbohydrate substituted) glycerol teichoic acid fragments. Teichoic acid fragments, up to the dodecamer level, were assembled by means of phosphoramidite chemistry, using a relatively small excess of the building blocks and a repetitive efficient purification procedure of the protected intermediates by fluorous solid phase extraction (F-SPE).